Moorfields consultant to speak on genetic eye disease during clinical visit to Dubai

Dr. Mariya Moosajee, consultant ophthalmologist at Moorfields Eye Hospital and an eminent researcher specialising in genetic eye disease, will be a keynote speaker at the 17th Emirates Society of Ophthalmology (ESO) conference (14-16 December 2017) in Dubai. Dr. Moosajee will speak on ‘genomic medicine for inherited retinal diseases’, and will be joined at the conference by colleagues and fellow speakers from Moorfields Eye Hospital London, Dubai and Abu Dhabi.

Dr. Moosajee’s clinical focus is on developing a genomic service for children and adults affected with genetic eye disease. She will also be consulting patients through dedicated genetic clinics with genetic testing and counselling for families to be held at Moorfields in Dubai, during her visit.

According to Dr Moosajee, we are entering an era of personalised medicine, and in her presentation to ESO she will highlight how we are translating science to medicine using genome, stem cells, gene therapy and pharmacological small molecule drugs for the treatment of inherited retinal diseases.

Dr. Moosajee completed her NIHR academic clinical lectureship in 2016 and became the first ophthalmologist to be awarded the prestigious Wellcome Trust Beit Prize Clinical Research Development Fellowship. She has won 30 international and national prizes for her research and published over 40 peer-reviewed publications. She is also an honorary consultant ophthalmologist at Great Ormond Street Hospital for Children in London. In addition, she is a senior lecturer at the UCL Institute of Ophthalmology where she leads a large research team focused on identifying the genes that cause eye disease and developing new treatments for patients. She is a lecturer in communication skills, embryology and genetics at UCL and Imperial College London.

Speaking about the visit, Mariano Gonzalez, managing director at Moorfields Eye Hospital Dubai said:

“We are delighted to be hosting Dr. Moosajee in Dubai, where she will share her ground-breaking research work into a range of genetic eye diseases at the ESO conference and take time to meet patients and advise families, in a series of special clinics that we will host for her, at the hospital. Moorfields is also supporting ESO with several of our London, Dubai and Abu Dhabi based teams of consultant ophthalmologists speaking on their areas of special interest.”

Visiting consultant Dr Moosajee will conduct consultations, can organise genetic testing and provide counselling for patients and families that suffer from any form of genetic eye disease, ranging from birth and childhood eye defects to inherited retinal degeneration, at Moorfields Eye Hospital Dubai on Thursday 14 December 2017.

For more information or for bookings visit www.moorfields.ae/dubai, or call +9714 429 7888.

Notes to editors

About Moorfields Eye Hospital Dubai

Moorfields Eye Hospital Dubai (MEHD) is the first overseas branch of Moorfields Eye Hospital NHS Foundation Trust, the oldest and one of the largest centres for ophthalmic treatment, teaching and research in the world. Located at the Al Razi Medical Complex in Dubai Health Care City, the facility provides day case surgery and outpatient diagnostic and treatment services, for a variety of surgical and non-surgical eye conditions. MEHD will also raise standards for research and teaching in the region. MEHD is owned and managed by the NHS Foundation Trust, and maintains close links with London, to ensure that patients in the GCC receive the best eye care treatment in the world.

Media contact:

Jonathan Walsh, WPR Dubai, +971 50 4588610, jon@wprme.com

Was this information useful? Please rate the page.